Company News | Virotek Biosciences

Home
Tests & Services
Flagship product

Screenome™ is our most comprehensive flagship screening platform—your long-term genetic baseline for proactive care, built on four pillars of genetic risk.
Learn more
- Proactive Screening
- Comprehensive Disease Risk
- HerCan-TEK™
- Heredi-TEK™
- PRS-TEK™
- Personalized Medication & Wellness
- Pill-TEK™
- Rare Disease & Advanced Diagnostics
- Exo-TEK™
- Gene-TEK™
- Oncology & Cancer Care
- Early Detection
- CanScanPro™
- Treatment Strategy
- Onco-TEK™
- BRISA™
- HRD+™
About Us
Company News
Contact Us
Login Portal

October 21, 2025

Virotek Biosciences Becomes Canada’s First Commercial Lab to Deploy AVITI24™ for Translational Genomics and Multi-Omics Research

Virotek Biosciences announces the first commercial deployment in Canada of Element Biosciences’ AVITI24™ 5D multi-omic system for translational genomics and multi-omics research.

November 29, 2024

Virotek Biosciences Wins Innovation Category at Markham’s 34th Annual Business Excellence Awards

Virotek Biosciences has been honored with the Innovation Category Award at Markham’s 34th Annual Business Excellence Awards for contributions to cancer prevention, early detection, and personalized treatment.